HYBRIGENICS (EPA:ALHYG) | WebDisclosure

PRESS RELEASE

published on 04/23/2026 at 18:00, 6 months 4 days ago

B CELL DESIGN : COMMENT UNE INNOVATION BREVETÉE RÉPOND À UNE PÉNURIE MONDIALE DE RÉACTIFS DIAGNOSTIQUES
Le Groupe Aton publie un communiqué sur B Cell Design, société spécialisée en anticorps monoclonaux pour l'industrie du diagnostic in vitro, répondant aux besoins du secteur face aux tensions d'approvisionnement et réglementaires

Diagnostic In Vitro Sciences De La Vie Groupe Aton Anticorps Monoclonaux B Cell Design
BRIEF

published on 04/01/2026 at 18:05, 6 months 26 days ago

Aton Group: Towards a Reduction of Clinical Failures in Pharmaceuticals

Clinical Trials Pharmaceutical R&D Aton Group Predictability
BRIEF

published on 04/01/2026 at 18:05, 6 months 26 days ago

Groupe Aton : Vers une Réduction des Échecs Cliniques en Pharmaceutique

R&D Essais Cliniques Pharmaceutique Groupe Aton Prédictivité
PRESS RELEASE

published on 04/01/2026 at 18:00, 6 months 26 days ago

AMÉLIORER LE TAUX DE SUCCÈS DES ESSAIS CLINIQUES : UN ENJEU STRUCTURANT POUR LA RetD PHARMACEUTIQUE AU COEUR DE LA STRATÉGIE DU GROUPE ATON
Le Groupe Aton se concentre sur l'avant-clinique intelligent pour améliorer la prédictivité des décisions en R&D pharmaceutique et réduire le risque clinique. Prochaine publication sur Bcell Design et résultats annuels le 28 avril 2026

R&D Pharmaceutique Aton Avant-clinique Intelligent Risque Clinique Bcell Design
BRIEF

published on 03/11/2026 at 18:35, 7 months 16 days ago

Inoviem Scientific Advances Drug Development with Patient-Centric Approach

Personalized Medicine Pharmaceutical Innovation Inoviem Scientific Patient-centric Drug Development Preclinical Programs
BRIEF

published on 03/11/2026 at 18:35, 7 months 16 days ago

Inoviem Scientific Advances Développement de médicaments avec une approche centrée sur le patient

Médecine Personnalisée Innovation Pharmaceutique Inoviem Scientifique Développement De Médicaments Centré Sur Le Patient Programmes Précliniques
PRESS RELEASE

published on 03/11/2026 at 18:30, 7 months 16 days ago

ATON: UPDATE ON THE ACTIVITIES OF ITS SUBSIDIARY INOVIEM SCIENTIFIC
Aton Group's subsidiary, Inoviem Scientific, transforms drug development by prioritizing patient samples & AI technology, accelerating preclinical programs with high-value translational data

AI Technology Drug Development Inoviem Scientific Aton Group Patient Sample
BRIEF

published on 03/11/2026 at 18:20, 7 months 16 days ago

Inoviem Scientific : Avancées dans le Développement Pharmaceutique

Médecine Personnalisée Développement Pharmaceutique Pharmacologie Translationnelle Inoviem Scientific Plateforme Intégrée
BRIEF

published on 03/11/2026 at 18:20, 7 months 16 days ago

Inoviem Scientific: Advances in Pharmaceutical Development

Personalized Medicine Pharmaceutical Development Translational Pharmacology Inoviem Scientific Integrated Platform
PRESS RELEASE

published on 03/11/2026 at 18:15, 7 months 16 days ago

ATON : POINT D'AVANCEMENT SUR L'ACTIVITÉ DE LA FILIALE INOVIEM SCIENTIFIC
Le Groupe Aton via sa filiale Inoviem Scientific innove dans le développement de médicaments en utilisant des échantillons de patients pour des analyses moléculaires assistées par IA

Médecine Personnalisée Développement Pharmaceutique Groupe Aton Innovation Thérapeutique Inoviem Scientific

Published on 10/27/2026 at 23:40, 18 minutes ago

Second Closing of US$3.4 Million Private Placement
Published on 10/27/2026 at 23:25, 33 minutes ago

Gamma Resources Announces Leadership Transition: C. Connor Messler to Become Chief Executive Officer and Gabriel Alonso-Mendoza to Become Chairman; Grants Incentive Stock Options
Published on 10/27/2026 at 21:30, 2 hours 28 minutes ago

Apex Announces Closing of Over-Allotment Option
Published on 10/27/2026 at 21:15, 2 hours 43 minutes ago

Goldcliff Closes First Tranche of Private PLacement
Published on 10/27/2026 at 21:10, 2 hours 48 minutes ago

International Battery Metals Announces Leadership Transition

View all ACCESSWIRE

Published on 10/27/2026 at 22:40, 1 hour 18 minutes ago

EQS-Adhoc: NEXTDC Limited: Financial Covenants - Compliance and Headroom
Published on 10/27/2026 at 22:30, 1 hour 28 minutes ago

Tensor and Münchner Taxi Zentrum Sign LOI to Put Taxi Operators at the Center of Autonomous Mobility in Germany
Published on 10/27/2026 at 20:35, 3 hours 23 minutes ago

Piramal Pharma Limited Announces Results for Q2 and H1 FY27
Published on 10/27/2026 at 19:51, 4 hours 7 minutes ago

Statement re Possible Offer
Published on 10/27/2026 at 19:17, 4 hours 41 minutes ago

ZF Finance GmbH : Indicative Maximum Acceptance Amount in relation to the Tender Offer.

View all EQS

Published on 10/27/2026 at 18:00, 5 hours 58 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 22, 2026
Published on 10/27/2026 at 18:00, 5 hours 58 minutes ago

Nombre total de droits de vote et actions composant le capital social au 22 octobre 2026
Published on 10/27/2026 at 17:59, 5 hours 59 minutes ago

Q3 2026 sales
Published on 10/27/2026 at 17:59, 5 hours 59 minutes ago

Chiffre d’affaires du 3e trimestre 2026
Published on 10/27/2026 at 17:45, 6 hours 13 minutes ago

Haulotte - 2026 Q3 Sales

View all LES ECHOS COMFI WIRE

News